The SGMO Paradox: Analysts Bullish But Forecast -16.54% Fall
February 05, 2018 at 10:04 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Sangamo Therapeutics Inc (SGMO). The average 12-month price target for SGMO averaging the work of 5 analysts reveals an average price target of $16.40/share..
